News Sentiment

ASBP sentiment intelligence

Aspire BioPharma, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.24 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+3.8% over one week, -5.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 3.8% Price confirming higher
Trend fit Trend inactive -5.2% over four weeks
Fair value -99.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 33
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
TradingView 9
TradingKey 3
Stock Titan 2
Investing.com 2
ACCESS Newswire 2
simplywall.st 2
Treasure Coast News 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 15
Deals and strategy 3
Regulatory and legal 2
Capital return 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 45
Market source Direct company coverage

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)

Aspire Biopharma Holdings, Inc. announced that freestyle motocross legend Jarryd McNeil has been named a sponsored athlete for their BUZZ BOMB™ caffeine product line. This partnership aims to expand the brand's presence in action sports, leveraging McNeil's high-energy performanc

Tone
Positive 73/100
Event
Deals and strategy
Published
21 Jul 2026 04:12
Source
Market source
TradingView Direct company coverage

Aspire Bi clarifies public warrant terms after two reverse stock splits; exercise price now $13,800

Aspire Biopharma (ASBP) has clarified the terms of its public warrants following two reverse stock splits. The exercise price for these warrants is now $13,800, and the conversion ratio has been adjusted to 1,200 warrants per share of common stock. These changes result from a 1-f

Tone
Negative 18/100
Event
Market update
Published
20 Jul 2026 21:41
Source
TradingView
Treasure Coast News Direct company coverage

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

Aspire Biopharma Holdings, Inc. announced its successful participation in CPHI Frankfurt, where it engaged in strategic discussions with global pharmaceutical companies regarding its sublingual high-dose aspirin. The company reported positive final results from an investigational

Tone
Positive 75/100
Event
Regulatory and legal
Published
11 Jul 2026 17:40
Source
Treasure Coast News
Independent Mail Direct company coverage

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit

Aspire Biopharma's wholly-owned subsidiary, Buzz Bomb Caffeine Company, will showcase its BUZZ BOMB™ sublingual caffeine supplement at The Sports & Active Nutrition Summit USA from February 18-20 in San Diego, CA. The event provides a platform to demonstrate the rapid onset and c

Tone
Positive 68/100
Event
Market update
Published
11 Jul 2026 07:39
Source
Independent Mail
TradingView Direct company coverage

Price to earnings forward of Aspire Biopharma Holdings, Inc. – BOATS:ASBPW

This page provides financial information for Aspire Biopharma Holdings, Inc. (ASBPW), specifically focusing on its forward price-to-earnings ratio. However, the exact financial data for this metric is not displayed, indicating it might be unavailable or requires further navigatio

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 03:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Aspire Biopharma Holdings, Inc. – BOATS:ASBPW

This article focuses on the "Enterprise value to revenue forward" metric for Aspire Biopharma Holdings, Inc. (ASBPW). Published on TradingView, the content provides a snapshot of this financial ratio for the company, indicating whether the value has changed. The article itself do

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 19:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBPW

This article displays the "Price to book forward" for Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW) on TradingView. It provides a snapshot of the financial metric without further detailed analysis or historical data. The content is primarily a data point within the financial pl

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:39
Source
TradingView
TradingView Direct company coverage

Price to book forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP

This article provides financial information for Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP), specifically focusing on its price-to-book forward ratio. It notes that the market is currently closed with no trades, and the data is sourced from various financial providers. The pag

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 02:39
Source
TradingView
TradingView Direct company coverage

Number of shareholders of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP

This article provides details about Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP), focusing specifically on the number of its shareholders. It indicates that the company's market data is powered by ICE Data Services and FactSet, with SEC filings provided by Quartr. The content a

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 22:11
Source
TradingView
Finviz Direct company coverage

ASBP - Aspire Biopharma Holdings Inc Earnings

This article provides a detailed financial overview of Aspire Biopharma Holdings Inc. (ASBP), including its latest stock performance, market capitalization, key financial ratios, and analyst-related metrics. It highlights the company's recent closing price, percentage change, and

Tone
Negative 20/100
Event
Earnings
Published
03 Jul 2026 22:11
Source
Finviz
Stock Titan Direct company coverage

Alois Rubenbauer reports 65,000 shares in Aspire Biopharma (ASBP) Schedule 13G

Alois Ryan Rubenbauer III has filed a Schedule 13G, disclosing beneficial ownership of 65,000 shares of Aspire Biopharma Holdings, Inc. (ASBP). This represents 5.0% of the company's common stock, based on 1,295,234 shares outstanding as of March 31, 2026. The filing indicates a p

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 12:39
Source
Stock Titan
TradingView Direct company coverage

Enterprise value to EBITDA forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP

This article provides financial information for Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP), specifically focusing on its Enterprise Value to EBITDA forward metric. The data is presented within the TradingView platform context, indicating market closure and an absence of recen

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 03:11
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP

This article provides financial information for Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP), focusing specifically on its forward price-to-earnings ratio. The content is presented within the context of TradingView's platform, indicating that the data is intended for investors

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 01:40
Source
TradingView
Moomoo Direct company coverage

Aspire Biopharma(ASBP) Stock Options Chain | Quotes & News

This article provides access to the stock options chain for Aspire Biopharma (ASBP), along with quotes and news related to the company. It serves as a resource for investors interested in ASBP's options trading, price information, and recent developments.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 19:39
Source
Moomoo
Investing.com Direct company coverage

Aspire subsidiary launches caffeine stick packs on Amazon

Aspire Biopharma Holdings Inc., through its subsidiary Buzz Bomb Caffeine Company LC, has launched its caffeine stick packs on Amazon's U.S. store. The product offers 50 mg caffeine powder in waterless, sublingual stick packs in various flavors, targeting health-conscious consume

Tone
Positive 67/100
Event
Market update
Published
24 Jun 2026 13:40
Source
Investing.com
itemonline.com Direct company coverage

Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs

Aspire Biopharma's wholly owned subsidiary, Buzz Bomb Caffeine Company LC, has launched its innovative BUZZ BOMB™ 50mg caffeine stick packs on Amazon nationwide, offering a waterless, rapid-dissolve caffeine powder. This expansion aims to provide convenient and clean energy alter

Tone
Positive 71/100
Event
Market update
Published
24 Jun 2026 12:40
Source
itemonline.com
Stock Titan Direct company coverage

Aspire Biopharma puts 50 mg caffeine stick packs on Amazon

Aspire Biopharma (Nasdaq:ASBP) has launched its BUZZ BOMB™ 50 mg caffeine stick packs on Amazon, making them available nationwide. These sublingual, waterless powder packs are designed for rapid energy boosts without the need for water, targeting athletes, professionals, and busy

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 12:40
Source
Stock Titan
Chillicothe Gazette Direct company coverage

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution

Aspire Biopharma's wholly owned subsidiary, Buzz Bomb Caffeine Company, has partnered with Blue Shark Beverages to expand the distribution of its BUZZ BOMB™ sublingual caffeine stick packs across Southern California. This strategic agreement, effective February 1, aims to leverag

Tone
Positive 71/100
Event
Market update
Published
23 Jun 2026 15:39
Source
Chillicothe Gazette
Investing.com Direct company coverage

Aspire Biopharma stockholders approve warrant and share adjustment proposals

Aspire Biopharma Holdings, Inc. shareholders recently approved three warrant-related proposals at a special meeting on June 16, 2026. These approvals included authorizing share issuance upon warrant exercise, adjusting the number of exercisable shares, and approving voluntary exe

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 00:10
Source
Investing.com
Investing.com Canada Direct company coverage

Form 8K Aspire Biopharma Holdings Inc For: 22 June By Investing.com

This article announces that Aspire Biopharma Holdings Inc. filed a Form 8K on June 22. The filing is a significant event for the company, as Form 8K is used to notify investors of unscheduled material events or corporate changes. The article itself simply states the filing and pr

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:10
Source
Investing.com Canada
The Manila Times Direct company coverage

Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th

Aspire Biopharma Holdings, Inc. announced it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026, at 2:00 pm ET. The event offers an interactive online forum for investors and industry professionals to engage with mana

Tone
Positive 75/100
Event
Market update
Published
17 Jun 2026 23:01
Source
The Manila Times
TradingKey Direct company coverage

Aspire Biopharma Holdings Inc

This article provides a brief overview of Aspire Biopharma Holdings Inc. (ASBP), including its market capitalization, current stock price, and P/E TTM. It notes that key revenue breakdown data, both by business segment and by region, have not been disclosed by the company yet. Th

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 12:40
Source
TradingKey
TradingKey Direct company coverage

Aspire Biopharma Holdings Inc (ASBP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article details the dividend and stock split history for Aspire Biopharma Holdings Inc (ASBP). It notes that the company has not distributed any dividends over the past five years. However, it lists two significant stock split events: a 30-to-1 merger on May 7, 2026, and a 4

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 12:40
Source
TradingKey